Amwill Health Care Limited has announced the declaration of an interim dividend of ₹0.50 per equity share, representing 5% of the face value. This decision was made during the Board of Directors’ meeting held on October 23, 2026. The board also approved the unaudited financial results for the half-year ended September 30, 2026, along with the related statements and the limited review report.
Board Approves Financials and Declares Dividend
Amwill Health Care Limited’s Board of Directors met on October 23, 2026, to review and approve the company’s financial performance for the half-year ended September 30, 2026. The approved documents include the Unaudited Financial Results, Statement of Profit and Loss, Statement of Assets and Liabilities, and Statement of Cash Flows. These results have also undergone a limited review by the company’s statutory auditors, M/s SKLR & Co. LLP.
Interim Dividend Declared
In a move beneficial to its shareholders, the Board declared an interim dividend of ₹0.50 per equity share. This dividend represents 5% of the paid-up value of each equity share, with a face value of ₹10. The dividend is for the financial year 2026-27 and is expected to be paid within 30 days from the date of declaration. The board also fixed Friday, October 30, 2026, as the record date to determine the eligible shareholders for this interim dividend.
Unaudited Financial Highlights
The financial results for the half-year ended September 30, 2026, show a profit after tax of ₹367.39 lakhs. This compares to a profit after tax of ₹387.40 lakhs for the corresponding period in the previous year. The company’s revenue from operations for the period stood at ₹2,262.86 lakhs.
The Statement of Assets and Liabilities as at September 30, 2026, indicates total assets of ₹8,794.07 lakhs, with equity and liabilities totaling the same amount. The company’s paid-up equity share capital remains at ₹2,000.36 lakhs, with reserves and surplus amounting to ₹6,324.79 lakhs, resulting in a net worth of ₹8,325.15 lakhs.
Source: BSE
